secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARS Pharmaceuticals, Inc. (SPRY)
CIK:        0001671858
Form:       8-K
Filed at:   2026-07-17T20:02:07+00:00
Accession:  0001193125-26-307773
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ARS Pharma board member Lowenthal resigns; CMO Tanimoto terminated without cause
--------------------------------------------------------------------------------

- Richard Lowenthal resigned from the Board effective July 15, 2026, as a condition for severance.
- CMO Sarina Tanimoto ceased employment on July 15, 2026, under termination without cause.
- Lowenthal receives $217,350 and Tanimoto $111,780 as prorated 2026 target bonus payments.
- Severance and bonus payments conditioned on execution of release of claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671858/000119312526307773/0001193125-26-307773-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671858/000119312526307773/d168709d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-307773

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer